한국의 정신보건에 대한 보건경제학적 접근

참고문헌 (79)

1. McPake B, "Health economics: an international perspective", pp.1~8 (2008), Routledge
2. 최진우, "보건의료 정상화를 위한 국민의료비 확충방안 연구: OECD 보건통계를 기초로", 의료정책포럼, 4, pp.32~41 (2006)
3. "정형근 이사장 2012년부터 총액계약제 시행"[URL]
5. World Health Organization, "Mental health financing: Mental health policy & service guideline package", pp.14~15 (2003), WHO
6. 이선영, "국가정신보건정책의 발전방안", 정신건강정책포럼, 2, pp.3~36 (2008)
7. 양봉민, "보건경제학", pp.16~41 (2006), 나남출판
8. Newhouse JP, "The economics of medical care" (1978), Addison-Wesley
9. Organization for Economic Cooperation and Development (OECD), "OECD health data 2005" (2005), OECD
10. 권태호, "미국 의보개혁안 통과. 한겨레신문 2010년 3월 22일: 1면", ~ (2010)
11. Arrow KJ, "Uncertainty and the welfare economics of medical care", Am Econ Rev, 53, pp.941~973 (1963)
12. 강동세, "의사의 권리와 의무. 고려대학교 제16기 의료법학고위과정 교재", pp.4~5 (2005), 고려대학교 의료법학연구소
13. "의료분쟁법 심의 착수 - 머리에서 발끝까지 이슈"[URL]
14. Drummond MF, "Methods for the economic evaluation of health care programmes", pp.8~9 (2005), Oxford University Press
15. Drummond M, "Cost-of-illness studies: a major headache?", Pharmacoeconomics, 2, pp.1~4 (1992)
16. Ludbrook A, "A cost-effectiveness analysis of the treatment of chronic renal failure", Applied Economics, 13, pp.337~350 (1981)
17. Hull R, "Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosis", N Engl J Med, 304, pp.1561~1567 (1981)
18. Mehrez A, "Quality-adjusted life years, utility theory, and healthy-years equivalents", Med Decis Making, 9, pp.142~149 (1989)
19. Tan-Torres ET, "WHO guide to cost-effectiveness analysis" (2003), WHO
20. Boyle MH, "Economic evaluation of neonatal intensive care of very-low-birth-weight infants", N Engl J Med, 308, pp.1330~1337 (1983)
21. Oldridge N, "Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction", Am J Cardiol, 72, pp.154~161 (1993)
22. Weisbrod BA, "Alternative to mental hospital treatment. II. Economic benefit-cost analysis", Arch Gen Psychiatry, 37, pp.400~405 (1980)
23. Rice DP, "Cost-of-illness studies: fact or fiction?", Lancet, 344, pp.1519~1520 (1994)
24. O’Brien BJ, "Assessing the economic value of a new antidepressant. A willingness-to-pay approach", Pharmacoeconomics, 8, pp.34~45 (1995)
25. Shah A, "Mental health economic studies from developing countries reviewed in the context of those from developed countries", Acta Psychiatr Scand, 101, pp.87~103 (2000)
26. Shah A, "Economic burden of illness forum. Reply to Shiell", Aust J Ageing, 14, pp.7~ (1995)
27. Behrens C, "Cost of illness studies: no aid to decision making:reply to Shiell et al. (Health Policy, 8 (1987) 317-323)", Health Policy, 10, pp.137~141 (1988)
28. Maynard A, "Cost management: the economist’s viewpoint", Br J Psychiatry Suppl, 20, pp.7~13 (1993)
29. May PR, "Cost-efficiency of mental health delivery system. I. A review of the literature on hospotal care", Am J Public Health Nations Health, 60, pp.2060~2067 (1970)
30. May PR, "Cost efficiency of treatments for the schizophrenic patient", Am J Psychiatry, 127, pp.1382~1385 (1971)
31. Lindholm H, "Comparison of conventional neuroleptic therapy with depot neuroleptics. An attempt at economic evaluation", Acta Psychiatr Scand Suppl, 246, pp.52~56 (1973)
32. Murphy JG, "A cost-benefit analysis of community versus institutional living", Hosp Community Psychiatry, 27, pp.165~170 (1976)
33. Sharfstein SS, "Community care: costs and benefits for a chronic patient", Hosp Community Psychiatry, 27, pp.170~173 (1976)
34. Lapsley H, "The economics of institutional and non-institutional care for psychiatric patients in Economics and Health: 1981 Proceedings of the third Australian conference of health economists", pp.105~110 (1982), Health Research Project
35. Mcguire TG, "Research on economics and mental health, the past and future prospects in Economics and mental health", pp.1~14 (1992), Johns Hopkins University Press
36. Gunderson JG, "The cost of schizophrenia", Am J Psychiatry, 132, pp.901~906 (1975)
37. Davies LM, "Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom", Br J Psychiatry, 162, pp.38~42 (1993)
38. Cuffel BJ, "Treatment costs and use of community mental health services for schizophrenia by age cohorts", Am J Psychiatry, 153, pp.870~876 (1996)
39. Evers SM, "Costs of schizophrenia in The Netherlands", Schizophr Bull, 21, pp.141~153 (1995)
40. Stoudemire A, "The economic burden of depression", Gen Hosp Psychiatry, 8, pp.387~394 (1986)
41. Kind P, "The costs of depression", Int Clin. Psychopharmacology, 7, pp.191~195 (1993)
42. Jonsson B, "What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment", Br J Psychiatry, 164, pp.665~673 (1994)
43. Conley RW, "An approach to measuring the cost of mental illness", Am J Psychiatry, 124, pp.755~762 (1967)
44. Siegal L, "Economic and life consequences experienced by a group of individuals with panic disorder", Journal of Anxiety Disorders, 4, pp.201~211 (1990)
45. Hay JW, "The economic costs of Alzheimer’s disease", Am J Public Health, 77, pp.1169~1175 (1987)
46. Ernst RL, "The US economic and social costs of Alzheimer’s disease revisited", Am J Public Health, 84, pp.1261~1264 (1994)
47. Gray A, "Alzheimer’s disease: the burden of the illness in England", Health Trends, 25, pp.31~37 (1993)
48. Maynard A, "Data Note--9. Measuring the social costs of addictive substances", Br J Addict, 82, pp.701~706 (1987)
49. Rice DP, "Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988", Public Health Rep, 106, pp.280~292 (1991)
50. Forder J, "A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care", J Affect Disord, 38, pp.97~111 (1996)
51. Simon GE, "Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants", JAMA, 275, pp.1897~1902 (1996)
52. Shapiro J, "Cost effectiveness of individual vs. group cognitive behavior therapy for problems of depression and anxiety in an HMO population", J Clin Psychol, 38, pp.674~677 (1982)
53. Revicki DA, "Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients", Hosp Community Psychiatry, 41, pp.850~854 (1990)
54. Karon BP, "Treatment costs of psychotherapy versus medication for schizophrenics", Prof Psychol, 6, pp.293~298 (1975)
55. Linn MW, "Day treatment and psychotropic drugs in the aftercare of schizophrenic patients. A Veterans Administration cooperative study", Arch Gen Psychiatry, 36, pp.1055~1066 (1979)
56. Guillette W, "Day hospitalization as a cost-effective alternative to inpatient care: a pilot study", Hosp Community Psychiatry, 29, pp.525~527 (1978)
57. Dick P, "Day and full time psychiatric treatment: a controlled comparison", Br J Psychiatry, 147, pp.246~249 (1985)
58. Dickey B, "Patterns of service use and costs in model day hospital-in programs in Boston and Tucson", Hosp Community Psychiatry, 41, pp.419~424 (1990)
59. Franklin JL, "An evaluation of case management", Am J Public Health, 77, pp.674~678 (1987)
60. Hu TW, "Cost-effectiveness of alternative approaches in treating severely mentally ill in California", Schizophr Bull, 17, pp.461~468 (1991)
61. Hoult J, "Psychiatric hospital versus community treatment: the results of a randomised trial", Aust N Z J Psychiatry, 17, pp.160~167 (1983)
62. Knapp M, "Community mental health care for former hospital in-patients. Predicting costs from needs and diagnoses", Br J Psychiatry Suppl, 27, pp.10~18 (1995)
63. Merson S, "The cost of treatment of psychiatric emergencies: a comparison of hospital and community services", Psychol Med, 26, pp.727~734 (1996)
64. Sledge WH, "Day hospital", crisis respite care versus inpatient care, Part II: Service utilization and costs, 1996, pp.153, 1074~1083
65. Creed F, "Cost effectiveness of day and inpatient psychiatric treatment: results of a randomised controlled trial", BMJ, 314, pp.1381~1385 (1997)
66. Drummond MF, "Economic evaluation of a support program for caregivers of demented elderly", Int J Technol Assess Health Care, 7, pp.209~219 (1991)
67. Wimo A, "Cost-utility analysis of group living in dementia care", Int J Technol Assess Health Care, 11, pp.49~65 (1995)
68. Murphy JG, "A cost-benefit analysis of community versus institutional living", Hosp Community Psychiatry, 27, pp.165~170 (1976)
69. Weisbrod BA, "A guide to benefit-cost analysis, as seen through a controlled experiment in treating the mentally ill", J Health Polit Policy Law, 7, pp.808~845 (1983)
70. Bond GR, "An economic analysis of psychosocial rehabilitation", Hosp Community Psychiatry, 35, pp.356~362 (1984)
71. World Health Organization, "The global burden of disease: 2004 update" (2008), WHO
72. World Bank, "World Development Report 1993. Investing in health" (1993), Oxford University Press
73. World Health Organization, "The World Health Report 2001. Mental Health: Understanding, New Hope" (2001), WHO
74. Ustun TB, "Global burden of depressive disorders in the year 2000", Br J Psychiatry, 184, pp.386~392 (2004)
75. Murray CJ, "Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study", Lancet, 349, pp.1498~1504 (1997)
76. 박재현, "우리나라 국민의 정신질환으로 인한 질병부담 추정", 예방의학회지, 39(1), pp.39~45 (2006), 대한예방의학회
77. 조맹제, "한국 주요정신장애의 유병률 및 관련요인：2006 전국정신질환역학조사", 신경정신의학, 48(3), pp.143~152 (2009), 대한신경정신의학회
78. 김은주, "정신질환의 사회적 비용에 관한 연구", 석사, pp.2006
79. Gupta M, "Does evidence-based medicine apply to psychiatry?", Theor Med Bioeth, 28, pp.103~120 (2007)

관련 논문AI추천